Introduction: Functional impairment and reduced mobility are prevalent in patients on chronic hemodialysis (HD). The impact of HD on physical performance and mobility needs evaluation.
INTRODUCTION
Functional impairment is highly prevalent in the hemodialysis (HD) population and frequently involves impaired mobility. [1] [2] [3] [4] [5] The prevalence of functional impairment is only expected to increase in the aging HD population with increased co-morbidities and geriatric conditions including frailty. In fact 70% of HD patients met criteria for either frail or pre-frail, conditions of reduced physical capacity. 6 Functional impairment in HD patients has significant impact including increased risk of falls and hospitalizations, higher mortality and worse quality of life.
There is some evidence that functional impairment may worsen while on chronic HD. In nursing home residents who initiated HD, the degree of activities of daily living dependence increased significantly after HD initiation. 8 The immediate impact of the HD session on functional and physical performance is also concerning since HD patients may be impaired after each thrice weekly HD session. 9 In the majority of HD patients the post HD period is characterized by increased fatigue. Post dialysis fatigue coupled with impaired physical performance may lead to higher risk for falls and difficulty completing tasks on dialysis days. 9 This post HD fatigue has been associated with HD specific risk factors including hemodynamic changes during HD. 10 In addition to fatigue, hemodynamic changes during HD are also thought to lead to hypo-perfusion injury of end-organs. [11] [12] [13] Therefore, we sought to evaluate the association of changes in blood pressure during HD with changes in physical performance, as measured by gait speed, before and after dialysis.
METHODS
Participants: After approval from the Medical College of Wisconsin IRB, we recruited patients 50 years of age who were receiving thrice weekly chronic HD at a Milwaukee area hemodialysis center. We excluded any patients who required a wheelchair. See Figure 1 for details on participant recruitment. All participants provided written informed consent before beginning study procedures.
Data collection procedure: Participants completed a written survey regarding sociodemographics (e.g. age, race, and employment status), total number of years on hemodialysis, and their personal history of hypertension, diabetes mellitus, congestive heart failure (CHF), coronary artery disease (CAD), peripheral vascular disease (PVD), cirrhosis and stroke. The presence or absence of comorbid conditions were confirmed using the medical record and the primary cause of renal disease obtained from the end stage renal disease (ESRD) Registration Report.
Intradialytic measurements: We obtained all sitting blood pressure (BP) measurements (pre dialysis BP, dialytic BPs, and post dialysis BP) for the HD session. These measurements are routinely collected every 15-20 minutes using an automated sphygmomanometer. We calculated the change in BP from pre to post HD (post dialysis BP minus the pre dialysis BP) and the maximum drop in BP during HD (the pre-dialysis BP minus the minimum dialysis BP) for use as our intradialytic BP predictor variables. To fully characterize the intradialytic hemodynamics of our cohort we also determined the minimum BP (lowest BP from any BP readings during HD, including pre and post measurements), the mean BP (average of all the BPs during the HD session) and the ultrafiltration rate (net amount of fluid (ml) removed divided by the duration of HD (hours) divided by the participant's weight (kg)).
Gait speed measurement: Gait speed is a clinically validated measure that is associated with falls risk, hospitalization and mortality. [14] [15] [16] Gait speed was measured with a timed 4 meter walk. Participants would start 5 feet before the start of the 4 meters and continue for 5 feet after. The time would start once the patient's leg crosses the start line and stops when the patient's second leg crosses the stop line of the 4 meter distance. Timing was done manually using a stopwatch. Participants were asked 48 paƟents were screened to walk at a comfortable normal pace and to use any assistive device (cane or walker) they would typically use to walk this distance. Participants completed this twice pre dialysis and twice post dialysis. The post dialysis gait speed was measured after the participant was deemed stable to leave the dialysis unit. The gait speed was calculated by dividing the 4 meter length by the time in seconds. The change in gait speed was calculated as the difference between the pre HD speed and the post HD speed. The average of the two repetitions was used in analysis. Falls Efficacy Scale-International: During dialysis participants completed the Falls Efficacy Scale-International (FES-I). The FES-I is validated measure of fear of falling. 17 It includes 16 questions that asks about the concern for falling during completion of routine tasks such as; getting dressed, taking a shower, going to answer the telephone before it stops ringing and going up or down stairs. The 16 items are scored on a four point Likert scale and summarized by simple addition to yield a score ranging from 16 to 64. Lower scores indicate less concern for falls, with 16-19 as low concern, 20-27 moderate concern, and 28-64 as high concern.
Statistical Analysis: We present baseline characteristics as means (SD) or frequencies. We compared baseline characteristics between participants with change in gait speed of <-0.05m/s vs those with change in gait speed >-0.05m using two sample t-tests for continuous variables and chi-squared tests or exact-test for categorical variables. A change of 0.05m/s in gait speed is associated with a decline in self-reported mobility. 18 We then used linear regression models to evaluate the cross-sectional associations between the intradialytic BP variables and our primary outcome measure of change in gait speed. We also evaluated the association between UFR and change in gait speed. The association between the intradialytic BP variables and change in gait speed were then tested in four parallel multivariable regression models. Covariates in the model were selected first based on clinical relevance and then retained in the model if there was an association with change in gait speed indicated by a pvalue <0.1. The final model included age, BMI, presence of diabetes, and HD session duration. After noting the significant association of diabetes with change in gait speed we further explored our data and evaluated the differences in gait speed and intradialytic BPs between participants with diabetes and those without diabetes. Finally we evaluated the association between the intradialytic BP variables and FES-I (secondary outcome measure) and between FES-I score and change in gait speed using linear regression. SAS 9.4 (SAS Institute, Cary, NC) was used for the statistical analysis.
RESULTS
Demographics and comorbidities: Twenty-eight participants were included in this study, with all participants completing the gait speed but one participant not completing the FES-I questionnaire due to a missing form. The mean (SD) age was 64.0 (10.5) years. The majority of participants were male (71%) and about half were African American (46%) with the remainder mostly Caucasian. The median (25th%tile, 75th%tile) dialysis vintage was 2.45 (1.5, 5.1) years. The majority of participants had hypertension (85.7%) and diabetes (57.1%). The leading cause of their ESRD was diabetes (53.6%) followed by hypertension (35.7%). See Table 1 for further demographic and comorbid characteristics.
Intradialytic blood pressures: The mean (SD) systolic and diastolic BP were 134.7 (20.3) mmHg and 70.8 (11.3) mmHg. The average minimum systolic and diastolic BP were 113.6 (20.4) mmHg and 60.3 (12.5) mmHg. The differences in systolic and diastolic BP from pre to post dialysis was 210.6 (25.8) mmHg and 24.6 (10.5) mmHg. The maximum drop in SBP and DBP from pre-HD BP readings were 30.1 (21.2) mmHg and 15.9 (11.5) mmHg, respectively. The mean (SD) UFR was 8.4 (3.7) ml/kg/hr. (See Table 2 ). When comparing participants with diabetes compared to those without diabetes there were differences in BP variation with diabetics have a change in pre to post systolic and diastolic BP of 220.9 (23.5) mmHg and 27.9 (11.3) mmHg compared to 3.2 (22.7) mmHg and 20.3 (7.8) mmHg for non-diabetics (p 5 0.01 for SBP and 0.05 for DBP). The absolute drop in SBP and DBP were both higher for diabetics compared to non-diabetics (See Table 3 Table 2 ). Linear regression analysis showed change in gait speed was significantly associated with greater decrease in BP from pre to post dialysis for both systolic and diastolic BP (p 5 0.02 and p 5 0.04, respectively). Reduction in gait speed was also associated with maximum drop in SBP and DBP (p 5 0.01 and p 5 <0.01, respectively). There was no association with UFR (p 5 0.44). See Figure 2 for graphs of unadjusted linear regression analysis for change in SBP and DBP, absolutes drop in SBP and DBP and UFR. In the multivariable model the maximum drop in both SBP and DBP remained significant with a decrease in 0.02m/s for every 10 mmHg drop in systolic and 20.04m/s for every 10 mmHg of drop in diastolic. The change in BP from pre to post was no longer significantly associated with gait speed in the multivariable model (See Table 4 ).
Falls Efficacy Scale-International: The mean (SD) FES-I score for the cohort was 33.1 (12.7), with 22.2% having low concern for falls, 14.8% with moderate concern for falls and 63.0% with high concern for falls. There were no associations between the BP variables and the falls survey score. Neither was there an association between change in gait speed and FES-I score.
DISCUSSION
In this cross-sectional study of prevalent HD patients there were a significant association between intradialytic blood pressure changes and impaired physical performance post HD, as measured with gait speed. Specifically, greater decrease in SBP and DBP from pre to post HD and greater maximum drop in SBP and DBP during HD were both associated with a slower gait speed post HD. The maximum drop in SBP and DBP remained significantly associated after adjustment for relevant covariates. Furthermore, the diabetic status of participants was a risk factor for both greater decrease in intra-dialytic BP and decrease in gait speed. Participants with greater impairment in gait speed post HD did not have a higher concern for falls. Prior work has shown the high prevalence of functional impairment and decline in functional status in the HD population. 8, 19 However most studies have not focused on changes in physical performance over the course of a dialysis session, nor evaluated HD specific risk factors for impairment in performance. Although it is known that the HD process can lead to cardiac stress and post dialysis fatigue 10, 20, 21 the effect on physical performance has not been well quantified. The role of HD specific risk factors in physical performance impairment needs further exploration. In a small study of twelve patients it was noted that an HD session had a negative impact on postural balance, however there was no evaluation of an HD specific risk factor for the worsening balance. 22 Our study evaluated the relationship with intra-dialytic hemodynamics (an HD specific risk factor) and changes in mobility post HD. Our results suggest that greater drop in BP during dialysis, even in the absence of absolute hypotension (SBP < 100), can lead to impairment in gait speed adds important information on HD specific risk factors for functional impairment post HD. In addition we note that the change in BP from pre to post HD was not significantly associated with change in gait speed in the adjusted model; potentially indicating that the magnitude of drop in BP during the entire HD session may be more important than the change in BP from start to end. The change in BP from pre to post HD may not accurately demonstrate the patient's hemodynamic change during HD since a patient who becomes hypotensive may then have an intervention, such as decrease in ultrafiltration goal or saline resuscitation, to improve the BP leading to a higher post HD BP. Intra-dialytic hemodynamics may affect post HD physical performance through multiple mechanisms. First, hemodynamic instability during dialysis can lead to perfusion abnormalities and ischemic injury in endorgans, 12, 13, 23, 24 including large muscle groups. Hypoperfusion of muscle may lead to changes in post HD physical performance. Second, apart from a direct effect on muscle performance, physical performance may be reduced post HD due to lightheadedness that can accompany a rapid reduction in blood pressure, presumably from reduced cerebral perfusion. This lightheadedness may affect patient balance and thereby lead to patients reducing gait speed to compensate for the increased unsteadiness post HD. Finally muscle cramping which often accompanies hypotension and high ultrafiltration with rapid volume contraction 25 may lead to decreased gait speed. However in our data neither ultrafiltration volume nor ultrafiltration rate was associated with the change in gait speed. We did not measure the incidence of cramping in our study.
We note that participants with diabetes had greater decrease in BP during dialysis and greater decrease in gait speed. However, we found that the maximum drop in BP during HD was still significantly associated with gait speed after adjusting for the presence of diabetes. Thus, while persons with diabetes may have greater susceptibility to BP drops, the association of change in gait speed with changes in BP is not simply due to confounding with diabetes.
The decline in physical performance, as measured by gait speed has important clinical implications including falls, as reduction gait speed is known to worsen falls risk. 16, [26] [27] [28] Hemodialysis patients are already at higher risk for falls due to comorbidities such as neuropathy and vascular disease along with the dialysis center environment of wet floors and abundant tubing that often surround the dialysis chairs. 9, 29 Falls in HD patients are associated with a higher mortality risk compared to non-HD community dwellers. 9 Additionally, falls in the ESRD population may lead to more injuries such as fractures and bleeds, due to the presences of renal osteodystrophy and use of systemic heparin during HD session. The increase risk for falls is especially important as participants who had greater decrease in gait speed post HD did not describe any increased concern for falls based on responses to the FES-I. Thus patients may not be fully aware of their impaired mobility post HD and may not take appropriate precautions such as using a walker or cane. Reduced gait speed is also associated with increased mortality and hospitalization in the general and HD populations. 15, 16, 30 In our study the gait speed was only measured once post HD thus we are not able to comment on the long-term effects of post HD decrease in gait speed Figure 2 Graphs of blood pressure and ultrafiltration variables (shown on x-axis) and change in gait speed (shown on y-axis). on mortality or hospitalization. However it is likely that the risk of falls in the post HD time period will be increased in those with greater decrease in gait speed. Our study has the following limitations. The sample size was only 28 which does limit its generalizability to the HD population as a whole, however compared to United States national characteristics the prevalence of diabetes and HTN were similar as was the mean age of our cohort. In addition with our small sample size and four main predictor variables with two outcome measures we have increased chance of false positive associations. Specifically our diabetics vs non-diabetic analysis was based on trends noted in our data and not our primary hypothesis. We view our study as hypothesis generating and acknowledge the need for future studies. Second, we did not assess how long the changes in post HD gait speed lasted thus are unable to comment on how long patients may have impaired mobility. We also had no test specific to lower extremity muscle strength thus the change in gait speed may be due to lightheadedness or balance issues that may be related to post HD cerebral perfusion. Finally it is unclear if the change in gait speed of 20.02 to 20.04m/s per every 10 mmHg decrease in SBP or DBP has clinical relevance. Literature indicates that a substantial change in gait speed is 0.1m/s and a small meaningful change is 0.05m/s based on patient noted changes in ability to walk one block or climb one flight of stairs. 18 In out cohort 25% had a decrease in gait speed 0.1m/s and 39% had a decrease of 0.05m/s; demonstrating that a meaningful reduction in gait speed post HD is common.
CONCLUSIONS
Our study suggests that greater decrease in intra-dialytic BP is a risk factor for reduced gait speed post HD. These results should be confirmed and explored in larger studies with comprehensive evaluation of physical function measures. Patients with greater decrease in BP during HD and those with diabetes may require close evaluation post HD to avoid consequences of impaired mobility. Intra-dialytic BP change is potentially modifiable with techniques such as dialysate cooling, use of alpha-1 agonists medications, or change in modality to nocturnal HD or short frequent HD. [31] [32] [33] Thus further evaluation of stabilization of dialytic BPs as a method to prevent post HD physical impairment and reduce falls is warranted in the HD population.
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